Article
Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
2023-01-19
Abstract excerpt
<h4>Background: </h4> Anaplastic thyroid cancer (ATC) is a very rare disease with a remarkably poor prognosis and with no established effective drug therapy. This study aimed to report the outcomes of lenvatinib single-agent therapy as an initial drug treatment in ATC and investigate its safety and efficacy. <h4>Methods: </h4>: This retrospective cohort study included 56 patients with ATC with unresectable primar...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1be9e4e8-b678-55ed-bff0-3b88a0c08a83
- DOI
- 10.21203/rs.3.rs-2417369/v1